LeMaitre Vascular (LMAT) is a long-term growth play, one which made an interesting bolt-on deal in recent times, as this warrants a quick look at this undercovered long-term growth play.
The company has delivered on very steady low double-digit growth in recent years and long traded at very reasonable multiples, followed by (too) strong momentum in recent years, as shares now appear fairly valued at $25, despite an interesting deal.
The Business, The past
LeMaitre Vascular provides innovative products which allow surgeons to improve procedure efficiency. Besides better outcomes of such procedures, it should reduce